Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
EMR vs AMAT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
EMR vs AMAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Semiconductors |
| Market Cap | $83.18B | $339.90B |
| Revenue (TTM) | $18.32B | $28.37B |
| Net Income (TTM) | $2.44B | $7.00B |
| Gross Margin | 39.4% | 48.7% |
| Operating Margin | 19.4% | 29.2% |
| Forward P/E | 21.7x | 37.1x |
| Total Debt | $13.76B | $6.55B |
| Cash & Equiv. | $1.54B | $7.24B |
EMR vs AMAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMR vs AMAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 37 yrs, beta 1.52, yield 1.4%
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- Lower volatility, beta 1.52, Low D/E 67.8%, current ratio 0.88x
AMAT carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 21.1% 10Y total return vs EMR's 215.5%
- PEG 2.16 vs EMR's 4.81
- 4.4% revenue growth vs EMR's 3.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.4% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (21.7x vs 37.1x) | |
| Quality / Margins | 24.7% margin vs EMR's 13.3% | |
| Stability / Safety | Beta 1.52 vs AMAT's 2.14 | |
| Dividends | 1.4% yield, 37-year raise streak, vs AMAT's 0.4% | |
| Momentum (1Y) | +181.3% vs EMR's +39.9% | |
| Efficiency (ROA) | 19.3% ROA vs EMR's 5.8%, ROIC 33.3% vs 8.2% |
EMR vs AMAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMR vs AMAT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMAT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 1.5x EMR's $18.3B. AMAT is the more profitable business, keeping 24.7% of every revenue dollar as net income compared to EMR's 13.3%. On growth, EMR holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $18.3B | $28.4B |
| EBITDAEarnings before interest/tax | $4.7B | $8.4B |
| Net IncomeAfter-tax profit | $2.4B | $7.0B |
| Free Cash FlowCash after capex | $3.1B | $5.7B |
| Gross MarginGross profit ÷ Revenue | +39.4% | +48.7% |
| Operating MarginEBIT ÷ Revenue | +19.4% | +29.2% |
| Net MarginNet income ÷ Revenue | +13.3% | +24.7% |
| FCF MarginFCF ÷ Revenue | +17.0% | +20.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | -3.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +13.9% |
Valuation Metrics
EMR leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 36.6x trailing earnings, EMR trades at a 26% valuation discount to AMAT's 49.5x P/E. Adjusting for growth (PEG ratio), AMAT offers better value at 2.88x vs EMR's 8.11x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $83.2B | $339.9B |
| Enterprise ValueMkt cap + debt − cash | $95.4B | $339.2B |
| Trailing P/EPrice ÷ TTM EPS | 36.61x | 49.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.71x | 37.07x |
| PEG RatioP/E ÷ EPS growth rate | 8.11x | 2.88x |
| EV / EBITDAEnterprise value multiple | 18.89x | 40.39x |
| Price / SalesMarket cap ÷ Revenue | 4.62x | 11.98x |
| Price / BookPrice ÷ Book value/share | 4.13x | 16.96x |
| Price / FCFMarket cap ÷ FCF | 31.19x | 59.65x |
Profitability & Efficiency
AMAT leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
AMAT delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $12 for EMR. AMAT carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.1% | +34.3% |
| ROA (TTM)Return on assets | +5.8% | +19.3% |
| ROICReturn on invested capital | +8.2% | +33.3% |
| ROCEReturn on capital employed | +10.0% | +30.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.68x | 0.32x |
| Net DebtTotal debt minus cash | $12.2B | -$686M |
| Cash & Equiv.Liquid assets | $1.5B | $7.2B |
| Total DebtShort + long-term debt | $13.8B | $6.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.61x | 35.46x |
Total Returns (Dividends Reinvested)
AMAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMAT five years ago would be worth $33,048 today (with dividends reinvested), compared to $16,900 for EMR. Over the past 12 months, AMAT leads with a +181.3% total return vs EMR's +39.9%. The 3-year compound annual growth rate (CAGR) favors AMAT at 55.3% vs EMR's 22.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +9.3% | +59.6% |
| 1-Year ReturnPast 12 months | +39.9% | +181.3% |
| 3-Year ReturnCumulative with dividends | +84.1% | +274.4% |
| 5-Year ReturnCumulative with dividends | +69.0% | +230.5% |
| 10-Year ReturnCumulative with dividends | +215.5% | +2107.7% |
| CAGR (3Y)Annualised 3-year return | +22.6% | +55.3% |
Risk & Volatility
Evenly matched — EMR and AMAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMR is the less volatile stock with a 1.52 beta — it tends to amplify market swings less than AMAT's 2.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMAT currently trades 99.0% from its 52-week high vs EMR's 89.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 2.14x |
| 52-Week HighHighest price in past year | $165.15 | $432.81 |
| 52-Week LowLowest price in past year | $106.53 | $151.51 |
| % of 52W HighCurrent price vs 52-week peak | +89.6% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 48.4 | 61.0 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 6.1M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EMR as "Buy" and AMAT as "Buy". Consensus price targets imply 9.5% upside for EMR (target: $162) vs -0.5% for AMAT (target: $426). For income investors, EMR offers the higher dividend yield at 1.42% vs AMAT's 0.40%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $161.92 | $426.39 |
| # AnalystsCovering analysts | 41 | 53 |
| Dividend YieldAnnual dividend ÷ price | +1.4% | +0.4% |
| Dividend StreakConsecutive years of raises | 37 | 8 |
| Dividend / ShareAnnual DPS | $2.10 | $1.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +1.4% |
AMAT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
EMR vs AMAT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EMR or AMAT a better buy right now?
For growth investors, Applied Materials, Inc.
(AMAT) is the stronger pick with 4. 4% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Emerson Electric Co. (EMR) offers the better valuation at 36. 6x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMR or AMAT?
On trailing P/E, Emerson Electric Co.
(EMR) is the cheapest at 36. 6x versus Applied Materials, Inc. at 49. 5x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Applied Materials, Inc. wins at 2. 16x versus Emerson Electric Co. 's 4. 81x.
03Which is the better long-term investment — EMR or AMAT?
Over the past 5 years, Applied Materials, Inc.
(AMAT) delivered a total return of +230. 5%, compared to +69. 0% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: AMAT returned +20. 1% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMR or AMAT?
By beta (market sensitivity over 5 years), Emerson Electric Co.
(EMR) is the lower-risk stock at 1. 52β versus Applied Materials, Inc. 's 2. 14β — meaning AMAT is approximately 41% more volatile than EMR relative to the S&P 500. On balance sheet safety, Applied Materials, Inc. (AMAT) carries a lower debt/equity ratio of 32% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — EMR or AMAT?
By revenue growth (latest reported year), Applied Materials, Inc.
(AMAT) is pulling ahead at 4. 4% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to 0. 6% for Applied Materials, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMR or AMAT?
Applied Materials, Inc.
(AMAT) is the more profitable company, earning 24. 7% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMAT leads at 29. 2% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMR or AMAT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Applied Materials, Inc. (AMAT) is the more undervalued stock at a PEG of 2. 16x versus Emerson Electric Co. 's 4. 81x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 21. 7x forward P/E versus 37. 1x for Applied Materials, Inc. — 15. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 9. 5% to $161. 92.
08Which pays a better dividend — EMR or AMAT?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 4%, versus 0. 4% for Applied Materials, Inc. (AMAT).
09Is EMR or AMAT better for a retirement portfolio?
For long-horizon retirement investors, Emerson Electric Co.
(EMR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 4% yield, +206. 6% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMR: +206. 6%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMR and AMAT?
These companies operate in different sectors (EMR (Industrials) and AMAT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
EMR pays a dividend while AMAT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.